Yi‐Long Wu
Xihua University(CN)Ningbo University(CN)Fu Jen Catholic University(TW)University of Science and Technology of China(CN)Hubei University of Medicine(CN)North China University of Science and Technology(CN)Nanchang Institute of Technology(CN)Anhui University(CN)Hainan Normal University(CN)Harbin Medical University(CN)Henan University of Traditional Chinese Medicine(CN)Chinese University of Hong Kong(HK)Capital Medical University(CN)King's College London(GB)Xiamen University(CN)Shaoxing University(CN)Nantong University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Nankai University(CN)Sichuan University(CN)Guangdong General Hospital(CN)Cancer Institute (WIA)(IN)Affiliated Hospital of Nantong University(CN)First Affiliated Hospital of Xiamen University(CN)West China Hospital of Sichuan University(CN)Guangxi University of Chinese Medicine(CN)Taihe Hospital(CN)Peking University Shenzhen Hospital(CN)Shanghai Tenth People's Hospital(CN)Shanghai University of Medicine and Health Sciences(CN)Sanofi (China)(CN)Guangdong Academy of Medical Sciences(CN)Ruikang Affiliated Hospital of Guangxi Medical University(CN)CRUK Lung Cancer Centre of Excellence(GB)Jingzhou Central Hospital(CN)Baoji City Central Hospital(CN)Xiamen Chang Gung Hospital(CN)Guangzhou Medical University Cancer Hospital(CN)Guangdong Provincial People's Hospital(CN)First Affiliated Hospital of Henan University(CN)First Affiliated Hospital of Harbin Medical University(CN)Qilu Hospital of Shandong University(CN)Fu Wai Hospital(CN)Henan Provincial Center for Disease Control and Prevention(CN)First Affiliated Hospital Zhejiang University(CN)The Second Affiliated Hospital of Xiamen Medical CollegeState Key Laboratory of Medicinal Chemical BiologyChina Agricultural University(CN)Tianjin Medical University(CN)Southern Medical University(CN)Anhui Polytechnic University(CN)Lanzhou University(CN)Fuzhou University(CN)Chongqing Medical University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma(2009)8,200 cited
- → The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer(2016)4,558 cited
- → Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study(2011)4,075 cited
- → Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer(2013)3,387 cited
- → Lung cancer: current therapies and new targeted treatments(2016)3,315 cited
- → Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial